Earnings Feed
Start Free
Home/Insiders/Ambrogi Michael J.
AM
SEC Insider//CIK 0001654363

Ambrogi Michael J.

CIK 00016543631 companyMALVERN, PA
SEC Profile

Transactions

50

Companies

1

Filings

1

CIK

0001654363

Recent Transactions

50 trades
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$67.28/sh−2,623→ 220,867 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$66.66/sh−12,217→ 238,042 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$66.50/sh−1,151→ 223,490 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$65.49/sh−1,380→ 250,259 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$67.48/sh−3,798→ 220,867 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$11.46/sh+3,774→ 224,641 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$66.77/sh−4,228→ 224,665 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-07-22−3,774→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$67.39/sh−17,175→ 220,867 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-07-22−30,772→ 67,586 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$65.53/sh−400→ 228,893 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$11.46/sh+8,426→ 229,293 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-22$21.15/sh+30,772→ 251,639 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-07-22−8,426→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-21$11.46/sh+300→ 221,167 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-21$21.15/sh+3,021→ 223,888 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-21$65.07/sh−300→ 220,867 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-07-21−3,021→ 98,358 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-07-21$65.06/sh−3,021→ 220,867 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-07-21−300→ 8,426 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-04-14$71.75/sh−377→ 220,867 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-04-14$70.99/sh−27,142→ 221,244 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-04-14−35,745→ 44,514 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-04-14$7.15/sh+35,745→ 256,612 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-04-13−22,755→ 80,259 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-04-13$69.01/sh−22,755→ 220,867 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-04-13$7.15/sh+22,755→ 243,622 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-04-13$70.18/sh−8,226→ 248,386 total
  • Sale
    NovoCure Ltd$NVCR

    Restricted Share Units

    2020-03-06$69.53/sh−2,274→ 220,867 total
  • Award
    NovoCure Ltd$NVCR

    Restricted Share Units

    2020-03-03+14,415→ 223,141 total
  • Award
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2020-03-03+27,794→ 27,794 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-02-28$72.22/sh−2,673→ 208,726 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2020-02-27−6,173→ 6,172 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-02-27$79.45/sh+6,173→ 211,399 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-02-25$81.16/sh−11,647→ 205,226 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2020-02-24$88.26/sh+31,199→ 216,873 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Restricted Stock Units

    2020-02-24−31,199→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2019-11-04−33,793→ 96,651 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-11-04$14.37/sh+10,069→ 195,743 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-11-04$79.00/sh−36,957→ 185,674 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-11-04$21.15/sh+33,793→ 219,467 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2019-11-04−10,069→ 0 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-11-04$79.00/sh−33,793→ 185,674 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-11-04$79.00/sh−10,069→ 185,674 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2019-11-04−36,957→ 0 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-11-04$22.00/sh+36,957→ 222,631 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-06-19$22.00/sh+110,868→ 296,542 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-06-19$60.00/sh−110,868→ 185,674 total
  • Exercise/Conversion
    NovoCure Ltd$NVCR

    Options to Buy Ordinary Shares

    2019-06-19−110,868→ 36,957 total
  • Sale
    NovoCure Ltd$NVCR

    Ordinary Shares

    2019-06-06$54.79/sh−5,999→ 185,674 total

Companies

1

Recent Filings

1

Address

C/O NOVOCURE INC., 20 VALLEY STREAM PKWY SUITE 300

MALVERN, PA, 19355

View on SEC.gov